SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Loss Per Common Share |
The Company calculates basic loss per common share by dividing net loss by the weighted average number of common shares outstanding during the periods. Diluted loss per common share includes the impact from all dilutive potential common shares relating to outstanding convertible securities.
For the three months ended March 31, 2023 and 2022, basic and diluted weighted-average common shares outstanding were and , respectively. For the nine months ended March 31, 2023 and 2022, basic and diluted weighted-average common shares outstanding were and , respectively. The Company incurred a net loss for the three and nine months ended March 31, 2023 and 2022, and therefore, basic and diluted loss per share for the periods were the same because potential common share equivalent would have been anti-dilutive. The total potentially dilutive common shares outstanding at March 31, 2023 and 2022 that were excluded from diluted weighted-average common shares outstanding represent shares underlying outstanding stock options, RSUs, and warrants, and totaled and , respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liquidity Considerations |
Liquidity Considerations
The accompanying financial statements and notes have been prepared assuming the Company will continue as a going concern. For the nine months ended March 31, 2023 and the year ended June 30, 2022, the Company generated negative cash flows from operations of $5.2 million and $23.9 million, respectively, and had an accumulated deficit of $87.1 million and $81.8 million, respectively. Management has evaluated the Company’s expected cash requirements over the next twelve (12) months, including investments in additional sales and marketing and research and development, capital expenditures, and working capital requirements. Management believes the Company’s existing cash, funding available under the SVB Credit Facility and the subordinated line of credit (“Subordinated LOC”), expected improvements in the gross margin and lower cash requirements will enable the Company to fund planned operations for the next twelve (12) months.
Historically, the Company has not generated sufficient cash to fund its operations. The Company is continuing efforts to improve operational efficiencies and to generate revenue from its existing backlog. Management currently anticipates increased revenues as well as improvements in the Company’s gross margin over the next twelve (12) months. The Company has received new orders in the twelve-month period ended March 31, 2023 of approximately $51.7 million.
As of May 10, 2023, the Company had a cash balance of $1.4 million, $3.8 million remained available for future borrowings under the $14 million SVB Credit Facility and $4.0 million available for future draws under the Subordinated LOC. As of May 10, 2023, $4.6 million remained available under the Company’s ATM agreement. In addition, to support our operations and anticipated growth, we intend to explore additional sources of capital as needed. We also continue to execute our cost reduction, sourcing, pricing recovery initiatives in efforts to increase our gross margins and improve cash flow from operations. Any unforeseen factors in the general economy beyond management’s control could potentially have negative impact on the planned gross margin improvement plan. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||